https://www.selleckchem.com/pr....oducts/resiquimod.ht
9 (2.8) with a range from 9 to 23. The Braden scale (β = -.07 per point; 95% CI -0.09, -0.04, .001) was an independent predictor of increased LOS on UVA, but not on MVA when adjusted for other variables. For overall complications, as well as type of complication, the Braden scale score was not a significant predictor of complications on either UVA or MVA. In the sample population, the Braden scale did not demonstrate an ability to predict negative outcomes in head and neck surgery patients. Level 2b individual cohort study. Lev
Like
Comment
Share
